Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

Research from the IAVI Neutralizing Antibody Center and partners provides additional evidence for germline-targeting strategy of HIV vaccine development

May 31, 2024

New publications in Nature Immunology show primed B cells in mice and non-human primates and germline-targeting immunogens could drive MPER-specific precursors toward bnAbs.

Read more

Features

IAVI recognizes HIV Vaccine Awareness Day as new papers are published

May 17, 2024

Additional evidence advances germline targeting strategy for HIV vaccine development.

Read more

Features

IAVI’s Human Immunology Laboratory relocates samples to Africa, fulfilling capacity strengthening goal

May 7, 2024

Lab to close June 30, 2024.

Read more

Features

TB vaccine workshop report published in Frontiers in Tuberculosis

May 2, 2024

Workshop examined high-burden country data needs for future TB vaccine introduction.

Read more

Features

World Vaccine Congress highlights IAVI’s R&D from end to end

March 29, 2024

IAVI leaders to share updates on our emerging infectious disease R&D portfolio and our work to make much-needed vaccines and antibodies globally accessible.

Read more

Features

IAVI and partners kick-start CELEBRATE study to explore acceptability and feasibility of bnAbs for infant HIV prevention 

March 5, 2024

Study focuses on socio-behavioral research to enhance understanding of preferences and factors influencing bnAb adoption for infant indication.

Read more

Features

IAVI statement on mRNA HIV vaccine candidate trials

March 2, 2024

Response to Science news article.

Read more

Features

Championing domestic financing to promote a vibrant vaccine research and development enterprise in Africa

February 7, 2024

Advocating for financing for vaccine and health research, development, and innovation for Africa by Africa.

Read more